Logo image of PROC

PROCAPS GROUP SA (PROC) Stock Price, Quote, News and Overview

NASDAQ:PROC - Nasdaq - LU2376511205 - Common Stock - Currency: USD

1.01  -0.58 (-36.51%)

After market: 0.9501 -0.06 (-5.93%)

PROC Quote, Performance and Key Statistics

PROCAPS GROUP SA

NASDAQ:PROC (2/3/2025, 8:00:01 PM)

After market: 0.9501 -0.06 (-5.93%)

1.01

-0.58 (-36.51%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.84
52 Week Low0.5
Market Cap113.95M
Shares112.82M
Float19.15M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO12-09 2019-12-09


PROC short term performance overview.The bars show the price performance of PROC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

PROC long term performance overview.The bars show the price performance of PROC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PROC is 1.01 USD. In the past month the price decreased by -56.65%. In the past year, price decreased by -68.92%.

PROCAPS GROUP SA / PROC Daily stock chart

PROC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 71.52 882.60B
NVO NOVO-NORDISK A/S-SPONS ADR 27.7 403.33B
JNJ JOHNSON & JOHNSON 16.53 397.55B
AZN ASTRAZENECA PLC-SPONS ADR 21.54 241.77B
MRK MERCK & CO. INC. 12.2 235.74B
NVS NOVARTIS AG-SPONSORED ADR 14.09 220.97B
SNY SANOFI-ADR 14.43 148.30B
PFE PFIZER INC 8.34 147.00B
BMY BRISTOL-MYERS SQUIBB CO 52.47 121.33B
GSK GSK PLC-SPON ADR 8.14 79.20B
ZTS ZOETIS INC 28.21 75.35B
TAK TAKEDA PHARMACEUTIC-SP ADR 34.18 47.68B

About PROC

Company Profile

PROC logo image Procaps Group SA is an international healthcare and pharmaceutical company. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Company Info

PROCAPS GROUP SA

9, rue de Bitbourg

Luxembourg LU

CEO: Kyle P. Bransfield

Employees: 5500

Company Website: https://www.procapsgroup.com/

Investor Relations: https://investor.procapsgroup.com/

PROCAPS GROUP SA / PROC FAQ

What is the stock price of PROCAPS GROUP SA today?

The current stock price of PROC is 1.01 USD. The price decreased by -36.51% in the last trading session.


What is the ticker symbol for PROCAPS GROUP SA stock?

The exchange symbol of PROCAPS GROUP SA is PROC and it is listed on the Nasdaq exchange.


On which exchange is PROC stock listed?

PROC stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PROCAPS GROUP SA stock?

6 analysts have analysed PROC and the average price target is 5.1 USD. This implies a price increase of 404.95% is expected in the next year compared to the current price of 1.01. Check the PROCAPS GROUP SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PROCAPS GROUP SA worth?

PROCAPS GROUP SA (PROC) has a market capitalization of 113.95M USD. This makes PROC a Micro Cap stock.


How many employees does PROCAPS GROUP SA have?

PROCAPS GROUP SA (PROC) currently has 5500 employees.


Should I buy PROCAPS GROUP SA (PROC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PROCAPS GROUP SA (PROC) stock pay dividends?

PROC does not pay a dividend.


PROC Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PROC. When comparing the yearly performance of all stocks, PROC is a bad performer in the overall market: 96.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PROC Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

PROC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to PROC. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners2.94%
Ins Owners0.13%
Short Float %N/A
Short RatioN/A
Analysts
Analysts43.33
Price Target5.1 (404.95%)
EPS Next YN/A
Revenue Next YearN/A